{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T01:33:13Z","timestamp":1758331993347,"version":"3.44.0"},"reference-count":47,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","award":["R01DK113039","UO1DK122013"],"award-info":[{"award-number":["R01DK113039","UO1DK122013"]}],"id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Connie Frank Bone Laboratory"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Jansen metaphyseal chondrodysplasia (JMC) is an ultra-rare autosomal dominant disease that is caused by heterozygous, activating PTH1R mutations resulting in PTH- and PTHrP-independent hypercalcemia and hypercalciuria, leading to nephrocalcinosis and impaired renal function later in life. The activated PTH1R plays critical roles in mineral ion homeostasis and bone lengthening, as well as bone formation and resorption. Currently, little is known about bone turnover markers and bone histomorphometric changes in JMC patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study aimed to assess changes in bone microarchitecture, bone formation, and bone protein expression in 2 pediatric patients with JMC harboring the H223R-PTHR1 mutation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Bone histomorphometry, immunohistochemistry, and histologic analyses were conducted on iliac crest biopsy samples from 2 male siblings affected by JMC (ages 6 and 8 years) and 9 healthy control males of similar age, with normal kidney function.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Both patients with JMC displayed irregular bone architecture, increased osteoid, and a prolonged osteoid maturation process. While trabecular volume remained normal, immunohistochemical analysis demonstrated increased in PTH1R expression in both osteoblasts and fibroblastic cells on the bone surface. Cortical bone displayed areas of intense osteoclast activity and scattered marrow fibrosis. Remarkably, osteocytes in samples from patients with JMC had osteoid buildup within their lacunae and canaliculi that were both shorter and less abundant. DMP1 immunohistochemistry highlighted the abnormal canalicular network in patients. FGF23 staining in osteocytes was enhanced while sclerostin was diminished.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The H223R-PTH1R mutation in patients with JMC leads to bone structural irregularities, hypomineralization, abnormal osteocyte morphology, and altered expression of osteocyte-derived proteins. These findings underscore the multifaceted impact of the mutant PTH1R on bone physiology and focus attention on the osteocyte as a cellular target for therapeutic intervention. Whether normalizing gene expression in osteocytes is possible and can improve bone health in patients with JMC remains to be seen. Assessment of osteocyte morphology and function may provide novel diagnostic endpoints for future clinical trials with JMC therapeutics.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf097","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T15:25:00Z","timestamp":1739373900000},"page":"2729-2740","source":"Crossref","is-referenced-by-count":0,"title":["Jansen's Disease: Bone Abnormalities Beyond Chondrodysplasia"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9245-9606","authenticated-orcid":false,"given":"Renata C","family":"Pereira","sequence":"first","affiliation":[{"name":"Pediatric Nephrology, UCLA, Geffen School of Medicine , Los Angeles, CA 90095-8347 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M","family":"Delany","sequence":"additional","affiliation":[{"name":"Center for Molecular Oncology, UConn Health , Farmington, CT 06030 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Reyes","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Massachusetts General Hospital and Harvard Medical School , Boston, MA 02114 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Gales","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology, UCLA, Geffen School of Medicine , Los Angeles, CA 90095-8347 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7491-0515","authenticated-orcid":false,"given":"Harald","family":"J\u00fcppner","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Massachusetts General Hospital and Harvard Medical School , Boston, MA 02114 ,","place":["USA"]},{"name":"Pediatric Nephrology Unit, Massachusetts General Hospital and Harvard Medical School , Boston, MA 02114 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro B","family":"Salusky","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology, UCLA, Geffen School of Medicine , Los Angeles, CA 90095-8347 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"2025091917014206500_dgaf097-B1","first-page":"802","volume-title":"DeGroot's Endocrinology","author":"Gardella","year":"2023","edition":"8th ed"},{"issue":"1","key":"2025091917014206500_dgaf097-B2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/endo.134.1.8275957","article-title":"Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids","volume":"134","author":"Lee","year":"1994","journal-title":"Endocrinology"},{"key":"2025091917014206500_dgaf097-B3","first-page":"1038","volume-title":"Endocrinology","author":"Maes","year":"2016","edition":"7th ed"},{"key":"2025091917014206500_dgaf097-B4","first-page":"253","article-title":"\u00dcber atypische Chondrodystrophie (Achondroplasie) und \u00fcber eine noch nicht beschriebene angeborene Wachstumsst\u00f6rung des Knochensystems: Metaphys\u00e4re Dysostosis","volume":"61","author":"Jansen","year":"1934","journal-title":"Zeitschr Orthop Chir."},{"issue":"10","key":"2025091917014206500_dgaf097-B5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJM199609053351004","article-title":"Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia","volume":"335","author":"Schipani","year":"1996","journal-title":"N Engl J Med"},{"issue":"7","key":"2025091917014206500_dgaf097-B6","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1210\/jc.2018-00332","article-title":"Progression of mineral Ion abnormalities in patients with Jansen metaphyseal chondrodysplasia","volume":"103","author":"Saito","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025091917014206500_dgaf097-B7","first-page":"3584","article-title":"Hypercalcemia due to constitutive activity of the parathyroid hormone (PTH)\/PTH-related peptide receptor: comparison with primary hyperparathyroidism","volume":"81","author":"Parfitt","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2025091917014206500_dgaf097-B8","first-page":"1173","volume-title":"Vitamin D, Basic Research and its Clinical Application","author":"Rao","year":"1979"},{"key":"2025091917014206500_dgaf097-B9","first-page":"269","volume-title":"Pediatric Diseases Related to Calcium","author":"Frame","year":"1980"},{"issue":"4","key":"2025091917014206500_dgaf097-B10","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1210\/jc.2011-3082","article-title":"Potential effects of alendronate on fibroblast growth factor 23 levels and effective control of hypercalciuria in an adult with Jansen's metaphyseal chondrodysplasia","volume":"97","author":"Onuchic","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025091917014206500_dgaf097-B11","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1210\/jc.2016-2054","article-title":"Jansen metaphyseal chondrodysplasia due to heterozygous H223R-PTH1R mutations with or without overt hypercalcemia","volume":"101","author":"Nampoothiri","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025091917014206500_dgaf097-B12","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1046\/j.1523-1755.1998.00866.x","article-title":"Bone disease in children and adolescents undergoing successful renal transplantation","volume":"53","author":"Sanchez","year":"1998","journal-title":"Kidney Int"},{"issue":"Supplement_3","key":"2025091917014206500_dgaf097-B13","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.2215\/CJN.00460107","article-title":"Technical approach to iliac crest biopsy","volume":"3","author":"Hernandez","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2025091917014206500_dgaf097-B14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry Nomenclature committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025091917014206500_dgaf097-B15","first-page":"135","article-title":"Histomorphometric reference data of transiliac bone biopsy in children from 8 to 17 years old","volume":"75","author":"Vel\u00e1squez-Forero","year":"2018","journal-title":"Bol Med Hosp Infant Mex"},{"issue":"2","key":"2025091917014206500_dgaf097-B16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S8756-3282(99)00257-4","article-title":"Normative data for iliac bone histomorphometry in growing children","volume":"26","author":"Glorieux","year":"2000","journal-title":"Bone"},{"issue":"7","key":"2025091917014206500_dgaf097-B17","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00467-022-05812-x","article-title":"Plasma FGF23 is associated with left atrial remodeling in children on hemodialysis","volume":"38","author":"Sharma","year":"2023","journal-title":"Pedatr Nephol"},{"issue":"6","key":"2025091917014206500_dgaf097-B18","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease","volume":"45","author":"Pereira","year":"2009","journal-title":"Bone"},{"issue":"4","key":"2025091917014206500_dgaf097-B19","doi-asserted-by":"crossref","first-page":"e0152871","DOI":"10.1371\/journal.pone.0152871","article-title":"Bone canopies in pediatric renal osteodystrophy","volume":"11","author":"Pereira","year":"2016","journal-title":"PLoS One"},{"key":"2025091917014206500_dgaf097-B20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-0716-1028-2_17","article-title":"Assessment of osteocytes: techniques for studying morphological and molecular changes associated with perilacunar\/canalicular remodeling of the bone matrix","volume":"2230","author":"Dole","year":"2021","journal-title":"Methods Mol Biol"},{"issue":"7","key":"2025091917014206500_dgaf097-B21","doi-asserted-by":"crossref","first-page":"bqac054","DOI":"10.1210\/endocr\/bqac054","article-title":"Actions of parathyroid hormone ligand analogues in humanized PTH1R knockin mice","volume":"163","author":"Daley","year":"2022","journal-title":"Endocrinology"},{"issue":"10","key":"2025091917014206500_dgaf097-B22","doi-asserted-by":"crossref","first-page":"e10802","DOI":"10.1002\/jbm4.10802","article-title":"Substantially delayed maturation of growth plate chondrocytes in \u201chumanized\u201d PTH1R mice with the H223R mutation of Jansen's disease","volume":"7","author":"Reyes","year":"2023","journal-title":"JBMR Plus"},{"issue":"1","key":"2025091917014206500_dgaf097-B23","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1038\/s41467-021-26571-7","article-title":"Control of osteocyte dendrite formation by Sp7 and its target gene osteocrin","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"2025091917014206500_dgaf097-B24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11914-022-00753-8","article-title":"Pathways controlling formation and maintenance of the osteocyte dendrite network","volume":"20","author":"Wang","year":"2022","journal-title":"Curr Osteoporos Rep"},{"issue":"6","key":"2025091917014206500_dgaf097-B25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s11914-018-0492-2","article-title":"Non-renal related mechanisms of FGF23 pathophysiology","volume":"16","author":"Hanudel","year":"2018","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"2025091917014206500_dgaf097-B26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.semnephrol.2012.12.017","article-title":"Chronic kidney disease: mineral and bone disorder in children","volume":"33","author":"Wesseling-Perry","year":"2013","journal-title":"Semin Nephrol"},{"issue":"1","key":"2025091917014206500_dgaf097-B27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev-physiol-021119-034332","article-title":"The osteocyte: new insights","volume":"82","author":"Robling","year":"2020","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"2025091917014206500_dgaf097-B28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jbmr.226","article-title":"The biological function of DMP-1 in osteocyte maturation is mediated by its 57-kDa C-terminal fragment","volume":"26","author":"Lu","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2025091917014206500_dgaf097-B29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/bonekey.2014.38","article-title":"Functional heterogeneity of osteocytes in FGF23 production: the possible involvement of DMP1 as a direct negative regulator","volume":"3","author":"Lee","year":"2014","journal-title":"Bonekey Rep"},{"issue":"1","key":"2025091917014206500_dgaf097-B30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","article-title":"Disorders of bone remodeling","volume":"6","author":"Feng","year":"2011","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"2025091917014206500_dgaf097-B31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jbm4.10021","article-title":"Parathyroid hormone signaling in osteocytes","volume":"2","author":"Wein","year":"2018","journal-title":"JBMR Plus"},{"key":"2025091917014206500_dgaf097-B32","doi-asserted-by":"crossref","first-page":"967774","DOI":"10.3389\/fendo.2022.967774","article-title":"Roles of osteocytes in phosphate metabolism","volume":"13","author":"Michigami","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2025091917014206500_dgaf097-B33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41413-019-0051-1","article-title":"DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease","volume":"7","author":"Dussold","year":"2019","journal-title":"Bone Res"},{"issue":"10","key":"2025091917014206500_dgaf097-B34","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/jbmr.105","article-title":"Long-term clinical outcome and carrier phenotype in autosomal recessive hypophosphatemia caused by a novel DMP1 mutation","volume":"25","author":"M\u00e4kitie","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025091917014206500_dgaf097-B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1083\/jcb.33.1.1","article-title":"CHANGES IN THE FINE STRUCTURE OF BONE CELLS AFTER THE ADMINISTRATION OF PARATHYROID EXTRACT","volume":"33","author":"Cameron","year":"1967","journal-title":"J Cell Biol"},{"issue":"5","key":"2025091917014206500_dgaf097-B36","doi-asserted-by":"crossref","first-page":"e0125731","DOI":"10.1371\/journal.pone.0125731","article-title":"Parathyroid hormone induces bone cell motility and loss of mature osteocyte phenotype through L-calcium channel dependent and independent mechanisms","volume":"10","author":"Prideaux","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"2025091917014206500_dgaf097-B37","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.18632\/aging.101308","article-title":"Degeneration of the osteocyte network in the C57BL\/6 mouse model of aging","volume":"9","author":"Tiede-Lewis","year":"2017","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"2025091917014206500_dgaf097-B38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11914-022-00766-3","article-title":"Osteocyte remodeling of the lacunar-canalicular system: what's in a name?","volume":"21","author":"Heveran","year":"2023","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"2025091917014206500_dgaf097-B39","first-page":"292","article-title":"Physiological and pathological osteocytic osteolysis","volume":"18","author":"Tsourdi","year":"2018","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"25","key":"2025091917014206500_dgaf097-B40","doi-asserted-by":"crossref","first-page":"e2023999118","DOI":"10.1073\/pnas.2023999118","article-title":"Disrupted osteocyte connectivity and pericellular fluid flow in bone with aging and defective TGF-\u03b2 signaling","volume":"118","author":"Schurman","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2025091917014206500_dgaf097-B41","first-page":"3052","article-title":"A novel parathyroid hormone (PTH)\/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia","volume":"84","author":"Schipani","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025091917014206500_dgaf097-B42","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s002239900367","article-title":"The effect of PTH antagonist BIM-44002 on Serum calcium and PTH levels in hypercalcemic hyperparathyroid patients","volume":"61","author":"Rosen","year":"2014","journal-title":"Calcif Tissue"},{"issue":"9","key":"2025091917014206500_dgaf097-B43","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1210\/endo.137.9.8756569","article-title":"Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH\/PTHrP receptors","volume":"137","author":"Gardella","year":"1996","journal-title":"Endocrinology"},{"issue":"4","key":"2025091917014206500_dgaf097-B44","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1210\/endo.142.4.8103","article-title":"Selective and nonselective inverse agonists for constitutively active type-1 parathyroid hormone receptors: evidence for altered receptor conformations","volume":"142","author":"Carter","year":"2001","journal-title":"Endocrinology"},{"issue":"1","key":"2025091917014206500_dgaf097-B45","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jbmr.2917","article-title":"Prolonged pharmacokinetic and pharmacodynamic actions of a pegylated parathyroid hormone (1-34) peptide fragment","volume":"32","author":"Guo","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025091917014206500_dgaf097-B46","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jbmr.3913","article-title":"An inverse agonist ligand of the PTH receptor partially rescues skeletal defects in a mouse model of Jansen's metaphyseal chondrodysplasia","volume":"35","author":"Noda","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2025091917014206500_dgaf097-B47","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1021\/jacs.3c09694","article-title":"Backbone modification provides a long-acting inverse agonist of pathogenic, constitutively active PTH1R variants","volume":"146","author":"Liu","year":"2024","journal-title":"J Am Chem Soc"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf097\/61898259\/dgaf097.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/10\/2729\/61898259\/dgaf097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/10\/2729\/61898259\/dgaf097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T21:01:52Z","timestamp":1758315712000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/10\/2729\/8015505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,2,14]]},"published-print":{"date-parts":[[2025,9,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf097","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"type":"print","value":"0021-972X"},{"type":"electronic","value":"1945-7197"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,2,14]]}}}